Erez Bar‐Haim

1.8k total citations
59 papers, 1.4k citations indexed

About

Erez Bar‐Haim is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Erez Bar‐Haim has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Immunology and 20 papers in Infectious Diseases. Recurrent topics in Erez Bar‐Haim's work include Immunotherapy and Immune Responses (19 papers), Bacillus and Francisella bacterial research (17 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). Erez Bar‐Haim is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Bacillus and Francisella bacterial research (17 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). Erez Bar‐Haim collaborates with scholars based in Israel, United States and France. Erez Bar‐Haim's co-authors include Lea Eisenbach, Avigdor Shafferman, Ofer Cohen, Ezra Vadai, Hagai Cohen, Boaz Tirosh, Uri Elia, Baruch Velan, Shahar Rotem and Mati Fridkin and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nano Letters.

In The Last Decade

Erez Bar‐Haim

59 papers receiving 1.3k citations

Peers

Erez Bar‐Haim

IMMUN

ONCOL

GENET

Michael H. Shearer United States

Nicolas Çuburu United States

Bolyn Hubby United States

Peter H. Goff United States

Frank Liang Sweden

Yongqing Li China

Shuguang Tan China

Franck Halary France

Katarina Radošević Netherlands

Chawaree Chaipan United States

Michael H. Shearer United States

Erez Bar‐Haim

537 ×0.9

IMMUN

358 ×0.7

188 ×0.5

212 ×0.7

ONCOL

172 ×0.8

GENET

Citations per year, relative to Erez Bar‐Haim Erez Bar‐Haim (= 1×) peers Michael H. Shearer

Countries citing papers authored by Erez Bar‐Haim

Since Specialization

Citations

This map shows the geographic impact of Erez Bar‐Haim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erez Bar‐Haim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erez Bar‐Haim more than expected).

Fields of papers citing papers by Erez Bar‐Haim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erez Bar‐Haim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erez Bar‐Haim. The network helps show where Erez Bar‐Haim may publish in the future.

Co-authorship network of co-authors of Erez Bar‐Haim

This figure shows the co-authorship network connecting the top 25 collaborators of Erez Bar‐Haim. A scholar is included among the top collaborators of Erez Bar‐Haim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erez Bar‐Haim. Erez Bar‐Haim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elia, Uri, Yinon Levy, Hagai Cohen, et al.. (2025). Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague. Advanced Science. 12(26). e2501286–e2501286. 3 indexed citations

Cohen-Gihon, Inbar, Galia Zaide, Sharon Amit, et al.. (2024). Genome sequence of two novel virulent clinical strains of Burkholderia pseudomallei isolated from acute melioidosis cases imported to Israel from India and Thailand. BMC Genomic Data. 25(1). 47–47. 1 indexed citations

Kon, Edo, Yinon Levy, Uri Elia, et al.. (2023). A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances. 9(10). eadg1036–eadg1036. 61 indexed citations

Eliakim‐Raz, Noa, Amos Stemmer, Noam Erez, et al.. (2022). Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study. BMJ Open. 12(8). e061584–e061584. 4 indexed citations

Milo, Ron, Elsebeth Staun-Ram, Dimitrios Karussis, et al.. (2022). Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses. Frontiers in Immunology. 13. 868915–868915. 26 indexed citations

Elia, Uri, Srinivas Ramishetti, Ronit Rosenfeld, et al.. (2021). Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. 15(6). 9627–9637. 84 indexed citations

Yahav, Dafna, Benaya Rozen‐Zvi, Alaa Atamna, et al.. (2021). Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study). BMJ Open. 11(10). e055611–e055611. 15 indexed citations

Bar‐Haim, Erez, Shahar Rotem, Uri Elia, et al.. (2019). Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay. Cells. 8(9). 952–952. 9 indexed citations

Eisenkraft, Arik, et al.. (2016). Toxins as biological weapons for terror—characteristics, challenges and medical countermeasures: a mini-review. PubMed. 2(1). 7–7. 28 indexed citations

10.

Chitlaru, Theodor, Ma’ayan Israeli, Erez Bar‐Haim, et al.. (2016). Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA- (High Temperature Requirement A) Sterne Strain. Scientific Reports. 6(1). 18908–18908. 20 indexed citations

11.

Rotem, Shahar, Ofer Cohen, Erez Bar‐Haim, et al.. (2014). Protective Immunity against Lethal F. tularensis holarctica LVS Provided by Vaccination with Selected Novel CD8+ T Cell Epitopes. PLoS ONE. 9(1). e85215–e85215. 9 indexed citations

12.

Zauberman, Ayelet, Yehuda Flashner, Yinon Levy, et al.. (2013). YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia. PLoS ONE. 8(12). e83560–e83560. 9 indexed citations

13.

Zvi, Anat, Shahar Rotem, Erez Bar‐Haim, Ofer Cohen, & Avigdor Shafferman. (2011). Whole-Genome Immunoinformatic Analysis of F. tularensis: Predicted CTL Epitopes Clustered in Hotspots Are Prone to Elicit a T-Cell Response. PLoS ONE. 6(5). e20050–e20050. 14 indexed citations

14.

Bar‐Haim, Erez, Eran Zahavy, Hagai Cohen, et al.. (2010). The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis. PLoS ONE. 5(6). e11176–e11176. 38 indexed citations

15.

Bar‐Haim, Erez, et al.. (2008). Interrelationship between Dendritic Cell Trafficking and Francisella tularensis Dissemination following Airway Infection. PLoS Pathogens. 4(11). e1000211–e1000211. 63 indexed citations

16.

Mendelson, Itai, Orit Gat, Ronit Aloni-Grinstein, et al.. (2005). Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Vaccine. 23(48-49). 5688–5697. 23 indexed citations

17.

Lee, Sung‐Hyung, Erez Bar‐Haim, Arthur Machlenkin, et al.. (2004). In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Therapy. 11(3). 237–248. 19 indexed citations

18.

Carmon, Lior, Baruch Brenner, Adrian Paz, et al.. (2002). Characterization of novel breast carcinoma–associated BA46-derived peptides in HLA-A2.1/Db-β2mtransgenic mice. Journal of Clinical Investigation. 110(4). 453–462. 30 indexed citations

19.

Brenner, Baruch, Erica Rakowsky, Meora Feinmesser, et al.. (2001). Second neoplasms in patients with Merkel cell carcinoma. Cancer. 91(7). 1358–1362. 68 indexed citations

20.

Eisenbach, Lea, Erez Bar‐Haim, & Khaled El‐Shami. (2000). Antitumor vaccination using peptide based vaccines. Immunology Letters. 74(1). 27–34. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact